Best Penny Stocks Under 5 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.05 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.05. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Nikola OTCMKTS:NKLAQ$0.05 -0.01 (-10.00%) As of 03:25 PM EasternNikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$3.04 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$6.00 (+13,233.3% Upside)Volume97,704 sharesAverage Volume630,977 shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. T2 Biosystems NASDAQ:TTOO$0.03 +0.01 (+33.33%) As of 02:16 PM EasternT2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. More about T2 BiosystemsMarket Capitalization$631 thousandConsensus RatingHoldConsensus Price Target$5.00 (+16,566.7% Upside)Volume80,493 sharesAverage Volume583,170 sharesToday's Range$0.03▼$0.043. Omega Therapeutics OTCMKTS:OMGAQ$0.02 -0.02 (-53.75%) As of 03:40 PM EasternOmega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$2.21 millionP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$8.50 (+45,845.9% Upside)Volume32,967 sharesAverage Volume800,577 shares4. Viracta Therapeutics NASDAQ:VIRX$0.0098 0.00 (0.00%) As of 07/23/2025Viracta Therapeutics, Inc, a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. More about Viracta TherapeuticsMarket Capitalization$389 thousandP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$1.75 (+17,793.7% Upside)Average Volume1.11 million sharesToday's Range$0.0098▼$0.00985. Crypto OTCMKTS:CRCW$0.0008 +0.00 (+14.29%) As of 03:57 PM EasternThe Crypto Company does not have significant operations. It was previously involved in the provision of consulting and education services for distributed ledger technologies, for the building of technological infrastructure, and enterprise blockchain technology solutions. More about CryptoConsensus RatingModerate BuyVolume13.92 million sharesAverage Volume12.76 million sharesToday's Range$0.0007▼$0.000850-Day Range$0.0006▼$0.001152-Week Range$0.0005▼$0.00166. Syros Pharmaceuticals NASDAQ:SYRS$0.02 +0.00 (+2.56%) As of 03:59 PM EasternSyros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$537 thousandP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$3.33 (+16,566.7% Upside)Volume4,651 sharesAverage Volume225,228 shares7. Virpax Pharmaceuticals NASDAQ:VRPX$0.02 +0.00 (+0.50%) As of 03:03 PM EasternVirpax Pharmaceuticals, Inc, a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. More about Virpax PharmaceuticalsMarket Capitalization$25 thousandConsensus RatingHoldVolume658 sharesAverage Volume188,285 sharesToday's Range$0.02▼$0.0250-Day Range$0.02▼$0.468. SpringBig NASDAQ:SBIG$0.04 +0.00 (+0.67%) As of 03:44 PM EasternSpringBig Holdings, Inc develops and operates a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands in the United States and Canada. More about SpringBigMarket Capitalization$2.09 millionP/E Ratio-0.56Consensus RatingHoldConsensus Price Target$1.00 (+2,122.2% Upside)Volume73,290 sharesAverage Volume65,975 shares9. BIOLASE NASDAQ:BIOL$0.0010 0.00 (0.00%) As of 07/23/2025BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. More about BIOLASEMarket Capitalization$33 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$1.20 (+119,900.0% Upside)Volume104 sharesAverage Volume2.58 million shares10. Zapata Computing NASDAQ:ZPTA$0.0020 +0.00 (+33.33%) As of 10:11 AM EasternZapata Computing Holdings Inc operates as an industrial generative artificial intelligence (AI) software company in the United States. More about Zapata ComputingMarket Capitalization$77 thousandConsensus RatingBuyConsensus Price Target$1.63 (+81,150.0% Upside)Volume1,328 sharesAverage Volume148,223 sharesToday's Range$0.00▼$0.0211. Medicine Man Technologies OTCMKTS:SHWZ$0.02 +0.02 (+809.09%) As of 07/23/2025 11:40 AM EasternMedicine Man Technologies, Inc, doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. More about Medicine Man TechnologiesConsensus RatingBuyConsensus Price Target$2.50 (+12,400.0% Upside)Volume5,857 sharesAverage Volume9,425 sharesToday's Range$0.00▼$0.0250-Day Range$0.00▼$0.03 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Alphabet’s Breakout Quarter Signals a New Leadership Phase Tesla Just Hit a Fork in the Road—Could the Bulls Lose Control? GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name? Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings? What's Behind Opendoor Technologies' Rally? Is Meme Mania Back? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
